Trials / Active Not Recruiting
Active Not RecruitingNCT06744140
Role of MRI Breast in Detection of Ductal Carcinoma in Situ
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Superior University · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
"This study investigates the role of Magnetic Resonance Imaging (MRI) in detecting Ductal Carcinoma in situ (DCIS) in high-risk breast cancer patients.
Detailed description
Improved detection rates of DCIS in high-risk patients. Enhanced diagnostic accuracy, reducing false positives and negatives. Ductal Carcinoma in situ (DCIS) is a non-invasive breast cancer where abnormal cells are confined to the milk ducts. The Breast Imaging Reporting and Data System (BI-RADS) is a standardized scoring system used to classify breast imaging findings. Scores range from 0 (incomplete) to 6 (known biopsy-proven malignancy)."
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Magnetic Resonance Imaging (MRI) | To Evaluate the breast Magnetic Resonance Imaging (MRI) in detecting Ductal Carcinoma In Situ (DCIS) lesions among high-risk breast cancer patients while keeping the histopathology as a GOLD standard |
Timeline
- Start date
- 2024-02-15
- Primary completion
- 2024-07-01
- Completion
- 2025-03-21
- First posted
- 2024-12-20
- Last updated
- 2024-12-20
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06744140. Inclusion in this directory is not an endorsement.